ESC Professional Premium Access

How to treat a patient with heart failure and a left ventricular ejection fraction (LVEF) > 40%

Event: ESC Congress 2022
Topic: Treatment
Session type: Symposium
Date: 27 August 2022
Time: 11:15 - 12:15

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

4 presentations in this session

A patient with HF and LVEF > 40%: neurohumoral modulators.

Speaker: Professor S. Solomon (Boston, US)
Thumbnail

A patient with HF and LVEF > 40%: SGLT2 inhibitors.

Speaker: Professor J. McMurray (Glasgow, GB)
Thumbnail

A patient with HF and LVEF > 40%: exercise training.

Speaker: Associate Professor E. Van Craenenbroeck (Antwerp, BE)
Thumbnail

Putting it all together: what to do for a patient with heart failure and a left ventricular ejection fraction (LVEF) > 40%.

Speaker: Professor M. Jessup (Dallas, US)
Thumbnail

4 speakers from this session

Professor Scott Solomon

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
45 presentations
13 followers

Professor John J V McMurray

Western Infirmary, Glasgow (United Kingdom of Great Britain & Northern Ireland)
84 presentations
6 followers

Associate Professor Emeline Van Craenenbroeck

University Hospital Antwerp, Antwerp (Belgium)
5 presentations
0 follower

Professor Mariell Jessup

American Heart Association, Dallas (United States of America)
21 presentations
0 follower

This platform is supported by

logo Novo Nordisk